| |
|
|
|
PLx Pharma Inc.  
|
|
4.25 -0.1 (-0.02%) |
06-19 16:00 |
|
Open: |
4.3129 |
Pre close: |
4.35 |
Target:
|
5.42
|
|
High: |
4.3747 |
Low: |
4.25 |
Resistance:
|
4.64
5.00
|
|
Volume: |
4,168 |
Market Cap: |
37M |
Support:
|
4.06
3.38
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.26
 |
MACD |
MACD(12,26):
|
-0.01  |
|
MA(20): |
4.28 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
5.00 |
Stochastic Oscillator |
%K(14,3):
|
23.43 |
|
MA(250): |
6.00 |
%D(3): |
21.75 |
|
Average Volume(K) |
3-Month: |
1047
|
52-Week |
High:
|
9.41 |
|
10-Days: |
567 |
Low: |
3.20 |
|
RSI |
RSI(14):
|
48.53 |
Change(%): |
-31.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.860 |
Return on Equity (ttm) |
-68.1 |
Shares Out. (M) |
8.73 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
-42.4 |
Shares Float (M) |
4.26 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
-0.09 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.50 |
|
Forward EPS |
-1.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
33 |
|
Book Value (p.s.) |
3.750 |
EBITDA (p.s.) |
-0.703 |
P/E |
-2.28 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.13 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
337295456.00 |
|
Operating Margin |
-1740.66 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
